Compugen Ltd. Share Price TEL AVIV STOCK EXCHANGE
Equities
CGEN
IL0010852080
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
722.8 ILa | -1.97% | -3.56% | +5.06% |
03-08 | Truist Securities Adjusts Price Target on Compugen to $5 From $4, Maintains Buy Rating | MT |
03-05 | Transcript : Compugen Ltd., Q4 2023 Earnings Call, Mar 05, 2024 |
Sales 2024 * | 37.9M 14.18B 3.04B | Sales 2025 * | 35.29M 13.2B 2.83B | Capitalization | 173M 64.65B 13.84B |
---|---|---|---|---|---|
Net income 2024 * | -13M -4.86B -1.04B | Net income 2025 * | -29M -10.85B -2.32B | EV / Sales 2024 * | 4.56 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 4.9 x |
P/E ratio 2024 * |
-14.8
x | P/E ratio 2025 * |
-7.15
x | Employees | 68 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.62% |
Latest transcript on Compugen Ltd.
1 day | -1.97% | ||
1 week | -3.56% | ||
Current month | -22.55% | ||
1 month | -22.55% | ||
3 months | -25.58% | ||
6 months | +157.50% | ||
Current year | +5.06% |
Managers | Title | Age | Since |
---|---|---|---|
Anat Cohen-Dayag
CEO | Chief Executive Officer | 57 | 31/12/01 |
Alberto Sessa
DFI | Director of Finance/CFO | 61 | 31/10/22 |
Eran Ophir
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Sekhri
CHM | Chairman | 66 | 01/10/17 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 10/06/18 |
Gilead Halevy
BRD | Director/Board Member | 57 | 10/06/18 |
Date | Price | Change | Volume |
---|---|---|---|
01/05/24 | 722.8 | -1.97% | 76 188 |
30/04/24 | 737.3 | -3.42% | 106,521 |
25/04/24 | 763.4 | +1.85% | 76,116 |
24/04/24 | 749.5 | +4.58% | 53,478 |
Delayed Quote TEL AVIV STOCK EXCHANGE, May 01, 2024 at 03:13 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.37% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.13% | 24.63B | |
-24.34% | 18.2B | |
+26.31% | 12.01B | |
-3.84% | 11.76B | |
+12.64% | 10.4B | |
-4.12% | 9.94B |
- Stock Market
- Equities
- CGEN Stock
- CGEN Stock